Literature DB >> 19913210

Clostridium difficile and inflammatory bowel disease.

Ashwin N Ananthakrishnan1, Mazen Issa, David G Binion.   

Abstract

The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.

Entities:  

Mesh:

Year:  2009        PMID: 19913210     DOI: 10.1016/j.gtc.2009.07.003

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  18 in total

Review 1.  Surgical Management of Clostridium difficile Colitis.

Authors:  Ann K Seltman
Journal:  Clin Colon Rectal Surg       Date:  2012-12

Review 2.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

3.  Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; R Guzman-Perez; V Gainer; T Cai; S Churchill; I Kohane; R M Plenge; S Murphy
Journal:  Aliment Pharmacol Ther       Date:  2012-02-23       Impact factor: 8.171

Review 4.  Clostridium difficile infection: epidemiology, risk factors and management.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

5.  Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Authors:  Susana Fuentes; Els van Nood; Sebastian Tims; Ineke Heikamp-de Jong; Cajo J F ter Braak; Josbert J Keller; Erwin G Zoetendal; Willem M de Vos
Journal:  ISME J       Date:  2014-02-27       Impact factor: 10.302

6.  Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Authors:  Faith Rohlke; Neil Stollman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 7.  Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.

Authors:  Alexander Khoruts; Alexa R Weingarden
Journal:  Immunol Lett       Date:  2014-08-10       Impact factor: 3.685

Review 8.  Environmental risk factors for inflammatory bowel diseases: a review.

Authors:  Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

9.  Genetic risk factors for Clostridium difficile infection in ulcerative colitis.

Authors:  A N Ananthakrishnan; E C Oxford; D D Nguyen; J Sauk; V Yajnik; R J Xavier
Journal:  Aliment Pharmacol Ther       Date:  2013-07-14       Impact factor: 8.171

10.  Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.

Authors:  A N Ananthakrishnan; A Cagan; V S Gainer; S-C Cheng; T Cai; P Szolovits; S Y Shaw; S Churchill; E W Karlson; S N Murphy; I Kohane; K P Liao
Journal:  Aliment Pharmacol Ther       Date:  2014-03-18       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.